levetiracetam
Generic: levetiracetam
Labeler: hospira, inc.Drug Facts
Product Profile
Brand Name
levetiracetam
Generic Name
levetiracetam
Labeler
hospira, inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
levetiracetam 100 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0409-1886
Product ID
0409-1886_ba064ae4-ae86-4fc4-b0a9-0477d8db8727
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202869
Listing Expiration
2026-12-31
Marketing Start
2012-11-02
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04091886
Hyphenated Format
0409-1886
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
levetiracetam (source: ndc)
Generic Name
levetiracetam (source: ndc)
Application Number
ANDA202869 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/mL
Packaging
- 25 VIAL, SINGLE-DOSE in 1 CARTON (0409-1886-02) / 5 mL in 1 VIAL, SINGLE-DOSE (0409-1886-22)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "ba064ae4-ae86-4fc4-b0a9-0477d8db8727", "openfda": {"nui": ["N0000008486"], "unii": ["44YRR34555"], "rxcui": ["647121"], "spl_set_id": ["ed1b74a8-2a9b-4315-b051-673c7941cb13"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (0409-1886-02) / 5 mL in 1 VIAL, SINGLE-DOSE (0409-1886-22)", "package_ndc": "0409-1886-02", "marketing_start_date": "20121102"}], "brand_name": "LEVETIRACETAM", "product_id": "0409-1886_ba064ae4-ae86-4fc4-b0a9-0477d8db8727", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0409-1886", "generic_name": "LEVETIRACETAM", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LEVETIRACETAM", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "100 mg/mL"}], "application_number": "ANDA202869", "marketing_category": "ANDA", "marketing_start_date": "20121102", "listing_expiration_date": "20261231"}